touchRESPIRATORY were delighted to catch up with the International Primary Care Respiratory Group (IPCRG) Past-President Prof. Janwillem Kocks (GPRI & University of Groningen, Groningen, Netherlands; OPRI Singapore, Singapore) to discuss his term as President of the IPCRG, how the COVID pandemic affected this and the yearly conference, and the take home messages from this year’s IPCRG annual meeting.
The 11th IPCRG World Conference was held in Málaga from 5th-7th May, 2022.
Questions
- What have been the highs and lows of your term of office as President? (1:09)
- What were the take-home messages from this year’s IPCRG AGM? (3:45)
- What are the priorities of the IPCRG for the coming year? (4:52)
Disclosures: Janwillem Kocks discloses receiving grant/ research support from AstraZeneca, Boehringer Ingelheim, Chiesi Pharmaceuticals, GSK, TEVA, Valneva; serving on advisory boards for AstraZeneca; receiving honoraria from AstraZeneca, Boehringer Ingelheim, Chiesi Pharmaceuticals, GSK, TEVA, Mundi Pharma, MSD, COVIS Pharma; Janwillem Kocks holds <5% shares of Lothar Medtec GmbH and 72.5% of shares in the General Practitioners Research Institute.
Support:Â Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.
To find out more visit the IPCRG website here.
